New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

FibroBiologics, Inc.

Contributing Author

Recent Articles by FibroBiologics, Inc.

Sep-12	FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies FBLG GlobeNewswire
Sep-11	FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment FBLG GlobeNewswire
Sep-10	FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies FBLG GlobeNewswire
Aug-27	FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference FBLG GlobeNewswire
Jul-31	FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update FBLG GlobeNewswire
Jul-28	FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications FBLG GlobeNewswire
Jul-11	FibroBiologics to Present at the Advanced Wound Care Summit USA FBLG GlobeNewswire
Jul-09	FibroBiologics Confirms Ability to Manufacture CybroCell for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank FBLG GlobeNewswire
Jul-07	FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10 FBLG GlobeNewswire
Jun-16	FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing FBLG GlobeNewswire
Jun-16	FibroBiologics to Present at the BIO International Convention 2025 FBLG GlobeNewswire
Jun-09	FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer FBLG GlobeNewswire
May-16	FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting FBLG GlobeNewswire
May-14	FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update FBLG GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.